Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma2013 · 800 citations
2. 2Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired2009 · 1,759 citations
3. 3Improved Survival with Ipilimumab in Patients with Metastatic Melanoma2010 · 15,163 citations
4. 4TIL therapy broadens the tumor-reactive CD8⁺T cell compartment in melanoma patients2012 · 176 citations
5. 5Dissection of T-cell Antigen Specificity in Human Melanoma2012 · 161 citations